-
Neoadjuvant chemotherapy followed by radical trachelectomy versus upfront abdominal radical trachelectomy for patients with FIGO 2018 stage IB2 cervical cancer
Author: Li, Xiaoqi; Jiang, Zhaoxia; Lu, Jing; Chen, Xiaojun; Ge, Huijuan; Wu, Xiaohua; Li, Jin
Journal: GYNECOLOGIC ONCOLOGY. 2023; Vol. 169, Issue , pp. 106-112. DOI: 10.1016/j.ygyno.2022.12.002
-
Circulating T-cell receptor diversity as predictive biomarker for PARP inhibitors maintenance therapy in high grade serous ovarian cancer
Author: Shu, Tong; Zhou, Zhipeng; Bai, Jing; Xiao, Xiao; Gao, Min; Zhang, Nan; Wang, Hongguo; Xia, Xuefeng; Gao, Yunong; Zheng, Hong
Journal: GYNECOLOGIC ONCOLOGY. 2023; Vol. 168, Issue , pp. 135-143. DOI: 10.1016/j.ygyno.2022.11.013
-
Real-world applications of PARPi maintenance therapy for recurrent ovarian cancer: A single-center study in China
Author: Wang, Deng-Feng; Shi, Xun-Wei; Zhang, Can; Zhang, Jie; Liu, Hong; Huang, Jian-Ming; Zhang, Guo-Nan; Wen, Qing-Lian
Journal: GYNECOLOGIC ONCOLOGY. 2023; Vol. 170, Issue , pp. 25-31. DOI: 10.1016/j.ygyno.2022.12.014
-
Joint detection of multiple HPV-testing technologies and evaluation of clinicopathological characteristics discriminate between HPV-independent and low-copy HPV-associated cervical squamous cell carcinoma (CSCC) -an analysis of 3869 cases
Author: Lu, Linghui; Liu, Tianqi; Wang, Shunni; Li, Jing; Zhang, Feiran; Ning, Yan; Wang, Yiqin
Journal: GYNECOLOGIC ONCOLOGY. 2023; Vol. 170, Issue , pp. 59-69. DOI: 10.1016/j.ygyno.2023.01.001
-
Risk stratification and molecular heterogeneity of endometrial cancer and expression profile of TIM-3: A retrospective cohort study
Author: Zhang, Yubo; Yang, Ruiye; Xu, Chunyu; Zhang, Yanqin; Deng, Mengqi; Wu, Di; Tang, Fan; Liu, Xinyu; Han, Yiding; Zhan, Yang; Miao, Jinwei
Journal: GYNECOLOGIC ONCOLOGY. 2023; Vol. 170, Issue , pp. 210-220. DOI: 10.1016/j.ygyno.2023.01.024
-
A nomogram-based overall survival stratification to identify uterine sarcoma patients without distant metastases who may benefit from adjuvant radiotherapy
Author: Du, Junhong; Cheng, Yuemei; Hu, Dan; Xing, Yijuan; Yue, Ling; He, Ruifen; Li, Hongli; Liu, Chang; Liang, Xiaolei; Yang, Yongxiu
Journal: GYNECOLOGIC ONCOLOGY. 2023; Vol. 169, Issue , pp. 17-26. DOI: 10.1016/j.ygyno.2022.11.023
-
Generation and characterization of humanized affinity-matured EGFL6 antibodies for ovarian cancer therapy
Author: Tang, Huijuan; Fayomi, Adetunji P.; Bai, Shoumei; Gupta, Navneet; Cascio, Sandra; Yang, Dongli; Buckanovich, Ronald J.
Journal: GYNECOLOGIC ONCOLOGY. 2023; Vol. 171, Issue , pp. 49-58. DOI: 10.1016/j.ygyno.2023.02.004
-
Oncogenic SIRT7 inhibits GATA4 transcriptional activity and activates the Wnt signaling pathway in ovarian cancer
Author: Li, Guocheng; Xu, Wenwen; Li, Xuelin; Chen, Mengzhu; Shi, Yong; Wei, Mingming; Peng, Danhong
Journal: GYNECOLOGIC ONCOLOGY. 2023; Vol. 171, Issue , pp. 39-48. DOI: 10.1016/j.ygyno.2022.12.005
